Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. judge slashes $80 million Roundup jury verdict to $25.3 million

Published 15/07/2019, 23:07
Updated 15/07/2019, 23:07
© Reuters. The Bayer AG logo sits on display at the headquarters in La Garenne-Colombes, near Paris

By Jonathan Stempel

(Reuters) - A federal judge on Monday slashed a damages award Bayer AG (DE:BAYGn) owed a California man who blamed Roundup weed killer for his cancer, to $25.27 million (£20.19 million) from $80.27 million, while rejecting the company's bid for a new trial.

U.S. District Judge Vince Chhabria in San Francisco said evidence against the former Monsanto (NYSE:MON) Co, which Bayer bought last year, supported the $5.27 million in compensatory damages that a jury awarded Edwin Hardeman. He also said the jury acted reasonably in awarding punitive damages.

Chhabria nonetheless reduced punitive damages to $20 million from $75 million, saying that while Monsanto "deserves to be punished" the higher award was "constitutionally impermissible" because it was nearly 15 times the compensatory damages award.

"Monsanto's conduct, while reprehensible, does not warrant a ratio of that magnitude, particularly in the absence of evidence showing intentional concealment of a known or obvious safety risk," Chhabria wrote.

Hardeman said he used Roundup for many years starting in the 1980s to treat poison oak and weeds on his property.

He was diagnosed with non-Hodgkin's lymphoma in 2014, but is now in remission.

Hardeman is one of more than 13,400 plaintiffs who have sued Bayer and Monsanto over Roundup, saying the herbicide's active ingredient, glyphosate, is unsafe. His case was considered a bellwether for hundreds of similar cases before Chhabria.

In a statement, Bayer called Chhabria's decision "a step in the right direction," but said it still plans to appeal.

Bayer said the verdict and damages award "conflict with both the weight of the extensive science that supports the safety of Roundup, and the conclusions of leading health regulators in the U.S. and around the world that glyphosate is not carcinogenic."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Hardeman may appeal Chhabria's decision to reduce the damages award, which one of his lawyers, Michael Baum, in a statement called a "reversible error."

U.S. Supreme Court precedents limit the ratio of punitive to compensatory damages to 9 to 1.

"We are pleased that the judge denied Monsanto's motion to throw out the verdict, and recognised that Monsanto deserved to be punished," Jennifer Moore, a lawyer for Hardeman, said in an interview. "We disagree with any reduction in the jury verdict."

Bayer paid $63 billion for Monsanto.

The case is In re Roundup Products Liability Litigation, U.S. District Court, Northern District of California, No. 16-md-02741. The Hardeman case is Hardeman v Monsanto Co in the same court, No. 16-00525.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.